Vaccine Prevents Pancreatic Cancer's Return in 3-Year Trial
An mRNA vaccine induced durable and functional T-cell responses that were associated with a reduced risk of disease recurrence in patients with pancreatic cancer,
Source: healthday.com
Page 36 - Genentech News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Genentech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Genentech Today - Breaking & Trending Today
Pancreatic cancer vaccine prevents recurrence for three years in small trial
A pancreatic cancer vaccine has continued to protect a small group of patients from their cancer coming back, three years after receiving the jab, a new study says.
Source: yahoo.com
Moderna : AACR INT Head & Neck Poster -April 08, 2024 at 04:52 pm EDT
CT141 mRNA-4157 Individualized Neoantigen Therapy +...
Source: marketscreener.com
Biologics and Biosimilars Landscape: IP, Policy, and Market Developments | Fish & Richardson
In this review, we discuss the most important recent developments in the biosimilars space, including new biosimilar approvals and launches, litigation under the Biologics Price...
Source: jdsupra.com
Pancreatic cancer vaccine prevents recurrence for three years in small trial
A pancreatic cancer vaccine has continued to protect a small group of patients from their cancer coming back, three years after receiving the jab, a new study says.
Source: upi.com